HSIL, High Grade Squamous Intraepithelial Lesion clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
CASCADE 2002: PROTECT Study, "PRObiotics to TrEat Anal preCancer Trial
Sorry, not yet accepting patients
This study is focused on treatment of anal high-grade squamous intraepithelial lesions (HSIL) in persons with HIV (PWH), with the ultimate goal of applying the approach toward prevention of anal cancer in this population
at UCSF
Last updated: